Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amylyx Pharmaceuticals, Inc. - Common Stock (NQ: AMLX )

27.39 -0.48 (-1.72%)
Streaming Delayed Price Updated: 1:45 PM EDT, Sep 26, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 396,517
Open 28.00
Bid (Size) 27.30 (2)
Ask (Size) 27.40 (2)
Prev. Close 27.87
Today's Range 26.69 - 29.08
52wk Range 6.510 - 33.41
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Amylyx Pharmaceuticals Announces Donated CENTAUR Clinical Trial Data Now Available to Help Advance Science in ALS for Future Treatments and Discoveries
From Amylyx Pharmaceuticals, Inc.
Via Business Wire
Amylyx Pharmaceuticals Announces Publication of Preclinical Data Showing Potential Synergistic Effect of AMX0035 Compared to Individual Compounds
From Amylyx Pharmaceuticals
Via Business Wire

Performance

YTD
+51.58%
+51.58%
1 Month
+4.10%
+4.10%
3 Month
+37.43%
+37.43%
6 Month
+71.08%
+71.08%
1 Year
+51.58%
+51.58%

More News

Read More
Amylyx Pharmaceuticals Stock Sees Relative Strength Rating Rise To 98
Via Investor's Business Daily
4 Analysts Have This to Say About Amylyx Pharma
Via Benzinga
After Initial Skepticism FDA's Adcomm Backs Amylyx's Amyotrophic Lateral Sclerosis Hopeful
Via Benzinga
Why Is Amylyx Pharmaceuticals (AMLX) Stock Up 70% Today?
Via InvestorPlace
FDA Again Highlights Lacking Data From Amylyx's Amyotrophic Lateral Sclerosis Candidate
Via Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
Via Benzinga
US Stocks Flat, Crude Oil Rises 2%
Via Benzinga
The FDA's Mixed Messages Sent Amylyx Pharmaceuticals Stock Off A Cliff
Via Investor's Business Daily
Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
US Stocks Turn Higher, Nasdaq Jumps 100 Points
Via Benzinga
AeroVironment, Snap And Some Other Big Stocks Moving Higher On Thursday
Via Benzinga
AAPL Stock Alert: 13 Takeaways From the Latest Apple Event 2022
Via InvestorPlace
Dow Drops 100 Points; US Jobless Claims Fall Further Last Week
Via Benzinga
Amylyx Pharmaceuticals Announces FDA Advisory Committee Supports Approval of AMX0035 for the Treatment of ALS
From Amylyx Pharmaceuticals, Inc.
Via Business Wire
Amylyx Pharmaceuticals Stock Trading Halted Today
From Amylyx Pharmaceuticals, Inc.
Via Business Wire
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
Via Benzinga
Amylyx Pharmaceuticals Announces Posting of Briefing Documents for Second FDA Advisory Committee Meeting on AMX0035
From Amylyx Pharmaceuticals, Inc.
Via Business Wire
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
Via Benzinga
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
Via Investor's Business Daily
Amylyx Pharmaceuticals Reports Second Quarter 2022 Financial Results
From Amylyx Pharmaceuticals, Inc.
Via Business Wire
Global Multiple Sclerosis Drugs Market Size Projected To Reach $33 Billion By 2029
Via FinancialNewsMedia
Exposures COVID-19
Amylyx Pharmaceuticals Announces FDA Advisory Committee Will Reconvene to Review New Drug Application for AMX0035 for the Treatment of ALS on September 7, 2022
From Amylyx Pharmaceuticals, Inc.
Via Business Wire
7 Biotech Stocks to Buy for Q3
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.